Ulrike Baro (#2307)
- $ 2 B
- Biopharmaceuticals
- Germany
- F
- 76 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Ulrike Baro is one of the three daughters of Horst Sartorius, who passed on a 50% stake in biopharmaceutical firm Sartorius AG after his death in 1998. Her great-grandfather Florenz Sartorius founded the firm in 1870 to make analytical balances to measure small mass in laboratories. Sartorius AG, which went public in 1990, makes pharmaceutical and laboratory equipment. Today, the company has around 10,600 employees and annual revenue exceeding $2.5 billion.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Ulrike Baro’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Ulrike Baro’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.8B
(May 4, 2026)
© Iconic Billionaires